{"name":"Targacept","permalink":"targacept","crunchbase_url":"http://www.crunchbase.com/company/targacept","homepage_url":"http://www.targacept.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"336-480-2100","description":"","created_at":"Sat Dec 01 05:42:41 UTC 2012","updated_at":"Sat Dec 01 05:49:33 UTC 2012","overview":"<p>Targacept, Inc. is a biopharmaceutical company developing a diverse pipeline of NNR TherapeuticsTM.  NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.</p>","image":{"available_sizes":[[[150,54],"assets/images/resized/0022/3277/223277v1-max-150x150.jpg"],[[250,90],"assets/images/resized/0022/3277/223277v1-max-250x250.jpg"],[[250,90],"assets/images/resized/0022/3277/223277v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"President and CEO","person":{"first_name":"Stephen","last_name":"A. Hill","permalink":"stephen-a-hill","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"200 East First Street, Suite 300","address2":"","zip_code":"27101-4165","city":"Winston-Salem","state_code":"NC","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[144,150],"assets/images/resized/0022/3278/223278v1-max-150x150.jpg"],[[240,250],"assets/images/resized/0022/3278/223278v1-max-250x250.jpg"],[[433,450],"assets/images/resized/0022/3278/223278v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}